ATC Abstracts

American Transplant Congress abstracts

  • Home
  • Meetings Archive
    • 2020 American Transplant Congress
    • 2019 American Transplant Congress
    • 2018 American Transplant Congress
    • 2017 American Transplant Congress
    • 2016 American Transplant Congress
    • 2015 American Transplant Congress
    • 2013 American Transplant Congress
  • Keyword Index
  • Resources
    • 2016 Resources
      • 2016 Welcome Letter
      • ATC 2016 Program Planning Committees
      • ASTS Council 2015-2016
      • AST Board of Directors 2015-2016
    • 2015 Resources
      • 2015 Welcome Letter
      • ATC 2015 Program Planning Committees
      • ASTS Council 2014-2015
      • AST Board of Directors 2014-2015
      • 2015 Conference Schedule
  • Advanced Search

Pretransplant Serum Hyaluronic Acid Can Be a Prognostic Predictor in Adult-to-Adult Living Donor Liver Transplantation.

S. Mizuno,1 B. Das,2 Y. Iizawa,1 H. Kato,1 Y. Murata,1 A. Tanemura,1 N. Kriyama,1 Y. Azumi,1 M. Kishiwada,1 M. Usui,1 H. Sakurai,1 S. Isaji.1

1Hepatobiliary-Pancreatic and Transplant Surgery, Mie University, Tsu, Japan
2Hepatobiliary Pancreatic Surgery, Bangabandhu Sheikh Mujib Medical University, Dhaka, Bangladesh.

Meeting: 2016 American Transplant Congress

Abstract number: A202

Keywords: Liver transplantation

Session Information

Date: Saturday, June 11, 2016

Session Name: Poster Session A: Living Donor Liver Transplantation

Session Time: 5:30pm-7:30pm

 Presentation Time: 5:30pm-7:30pm

Location: Halls C&D

Related Abstracts
  • Impact of Renal Replacement Therapy Following Adult Living Donor Liver Transplantation, The
  • Impact of Pretransplant Sarcopenia and Sequential Changes in Sarcopenic Parameters After Living Donor Liver Transplantation

Objectives:

Recently, hyaluronic acid (HA) levels of the solution during graft preservation has been reported to be associated with primary non function in deceased donor liver transplantation. However, it still remains unclear whether preoperative serum HA levels can predict the outcome after adult-to-adult living donor liver transplantation (LDLT).

Patients and Methods:

[Study I] Twenty-one patients who underwent LDLT (2002.3-2004.2) were divided into two groups according to the preoperative serum HA levels: H-I group: HA >/= 500 ng/ml (n = 12, median HA: 994 ng/ml) and L-I group: HA <500 ng/ml (n = 9, HA: 421 ng/ml). We retrospectively investigated the surgical results, hepatocyte growth factor (HGF) levels and patient survival. [Study II] Seventy seven LDLT patients (2004.5-2014.12) were also divided into two groups: H-II group:(n = 40, median HA: 3333 ng/ml) and L-II group: (n = 37, HA: 244 ng/ml), and were compared liver regeneration ratio based on CT Volumetry (liver volume at 1 months after LDLT / standard liver volume), survival and investigated the prognostic risk factor.

Results:

[Study I] There were no significant differences of surgical results.Serum HA levels were significantly higher in H-I group than in L-I group at 1, 3, 5, and 7 days after LDLT. Postoperative liver function tests and HGF levels were significantly higher in H-I group than those in L-I group (H-I v.s. L-I: peak T-bil (mg/dl): 17.2 v.s. 6.2, p=0.013, p=0.005, HGF (pg/ml):1879 vs. 1092, p=0.03). The 1-year survival rate was significantly lower in H-I group (50%) than in L-I group (92.9%) (p=0.026).

[Study II] MELD score in H-II group was significantly higher than those in L-II group (21.1 vs. 12.7, p=0.002). The liver regeneration ratio did not differ between two groups (H-II v.s. L-II: 1.01 v.s. 1.04). The 1-, 5-, 10-year survival rate were significantly lower in H-II group than in L-II group (H-II v.s. L-II: 65.0%, 48.5%, 38.6% vs. 86.5%, 80.8%, 73.4%, p=0.004). In multivariate analysis, significant prognostic factors were preoperative HA >/= 500 ng/ml (p=0.004) and graft weight recipient bad weight ratio <0.8 (p=0.042).

Conclusion:

Preoperative HA can be one of important predict markers for recipient outcome.

CITATION INFORMATION: Mizuno S, Das B, Iizawa Y, Kato H, Murata Y, Tanemura A, Kriyama N, Azumi Y, Kishiwada M, Usui M, Sakurai H, Isaji S. Pretransplant Serum Hyaluronic Acid Can Be a Prognostic Predictor in Adult-to-Adult Living Donor Liver Transplantation. Am J Transplant. 2016;16 (suppl 3).

  • Tweet
  • Email
  • Print

To cite this abstract in AMA style:

Mizuno S, Das B, Iizawa Y, Kato H, Murata Y, Tanemura A, Kriyama N, Azumi Y, Kishiwada M, Usui M, Sakurai H, Isaji S. Pretransplant Serum Hyaluronic Acid Can Be a Prognostic Predictor in Adult-to-Adult Living Donor Liver Transplantation. [abstract]. Am J Transplant. 2016; 16 (suppl 3). https://atcmeetingabstracts.com/abstract/pretransplant-serum-hyaluronic-acid-can-be-a-prognostic-predictor-in-adult-to-adult-living-donor-liver-transplantation/. Accessed March 6, 2021.

« Back to 2016 American Transplant Congress

Most Viewed Abstracts

  • This Week
  • This Month
  • All Time
  • Role of Mitochondria, Metabolism and Inflammation: Pathways Influencing Short Term Outcomes Post-Renal Transplantation
    • Factors Influencing Creatinine Rise Following Donor Nephrectomy

    Visit Our Partner Sites

    American Transplant Congress (ATC)

    Visit the official site for the American Transplant Congress »

    American Journal of Transplantation

    The official publication for the American Society of Transplantation (AST) and the American Society of Transplant Surgeons (ASTS) »

    American Society of Transplantation (AST)

    An organization of more than 3000 professionals dedicated to advancing the field of transplantation. »

    American Society of Transplant Surgeons (ASTS)

    The society represents approximately 1,800 professionals dedicated to excellence in transplantation surgery. »

    Copyright © 2013-2021 by American Society of Transplantation and the American Society of Transplant Surgeons. All rights reserved.

    Privacy Policy

    loading Cancel
    Post was not sent - check your email addresses!
    Email check failed, please try again
    Sorry, your blog cannot share posts by email.
    This site uses cookies: Find out more.